Tissue Plasminogen Activator (t-PA) ELISA

Tissue-Type Plasminogen Activator (t-PA): Functions, Clinical Significance, and Applications

Introduction: Tissue-type plasminogen activator (t-PA) is a serine protease with a crucial role in fibrinolysis, the process by which blood clots are dissolved. It is widely distributed in blood plasma, serum, various body fluids, tissues, and the conditioned media of certain cultured cells.

Primary Functions:

1. Fibrinolysis:
• Conversion of Plasminogen: t-PA activates plasminogen, converting it into plasmin, the active protease.
• Degradation of Fibrin: Plasmin then breaks down fibrin, the principal component of blood clots, leading to the dissolution of the clot. This process is essential for resolving blood clots and restoring normal blood flow.
2. Metastatic Spread and Tissue Remodeling:
• Cancer Metastasis: t-PA is involved in the metastatic spread of malignant cells by facilitating their movement through tissues.
• Tissue Remodeling: It also plays a role in tissue remodeling by degrading extracellular matrix components.

Clinical Relevance:

1. Cardiovascular Diseases:
• Transplant Coronary Artery Disease: Alterations in t-PA plasma levels have been noted in patients with transplant coronary artery disease, a condition affecting the coronary arteries of cardiac transplant recipients.
• Thrombosis Risk: Low serum levels of t-PA activity are associated with an increased risk of thrombosis, highlighting its importance in preventing excessive clot formation.
2. Retinopathy in Type 1 Diabetes Mellitus:
• Elevated Serum Levels: Increased serum levels of t-PA have been linked to retinopathy, a serious complication of type 1 diabetes mellitus that affects the eyes.

Clinical Applications:

1. Thrombolytic Therapy:
• Stroke and Myocardial Infarction: Recombinant t-PA is used therapeutically to dissolve clots in conditions like ischemic stroke and myocardial infarction, improving patient outcomes by restoring blood flow to affected areas.
2. Diagnostic and Prognostic Marker:
• Monitoring Disease States: t-PA levels can serve as a diagnostic and prognostic marker for various conditions, including cardiovascular diseases and diabetic complications.

Conclusion: Tissue-type plasminogen activator (t-PA) is a critical enzyme in the fibrinolytic pathway, with significant roles in clot dissolution, cancer metastasis, and tissue remodeling. Its clinical relevance extends to cardiovascular diseases, diabetic retinopathy, and as a therapeutic agent in thrombolytic therapy. Monitoring t-PA levels can provide valuable insights into disease states and therapeutic responses, making it an important biomarker in both research and clinical settings.

This ELISA Kit from Tecan IBL International is for research use only.

Tecan IBL International offers a comprehensive range of ELISAs, immunoassays, antibodies and recombinant proteins.
Explore the full range >